Rejected at 4:50 p.m. Feb, 03, 2024 ] by herstein.jacob
Author: kpalazzo
Related Note: 1520725702188 1
Rationale for change

Hypophosphatemia is more relevant to the MOA of sevelamer because GI upset is common in many medications

Rejection reason

See discussion

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch Teriparatide, Vitamin D, Cinacalcet, Sevelamer
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo

Bootcamp
Watch associated Bootcamp video - Electrolytes: Phosphate

Watch associated Bootcamp video - Parathyroids : Hyperparathyroidism
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::04_Parathyroid::02_The_Unhealthy_Parathyroid_Calcium_Disorders #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::04_Parathyroid::02_The_Unhealthy_Parathyroid_Calcium_Disorders #AK_Step1_v12::#Pixorize::03_Pharmacology::09_Other_Endocrine_Pharm::07_Sevelamer #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::03_Thyroid,_Parathyroid,_Adrenal::03_Teriparatide,_Vitamin_D,_Cinacalcet,_Sevelamer #AK_Step2_v12::#B&B::15_Renal_and_Genitourinary::01_Renal_Failure::02_Chronic_Kidney_Disease::Extra #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::12_Sevelamer #AK_Step1_v12::#Bootcamp::Endocrinology::05_Parathyroids::04_Hyperparathyroidism #AK_Step1_v12::#Bootcamp::Nephrology::05_Electrolytes::05_Phosphate !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::07_Sevelamer